Table 1.
Baseline and intra-operative data of the entire cohort
| All patients (n = 669) | |
|---|---|
| Age (years) | 64.6 (11.2) |
| Gender: | |
| Male | 397 (59%) |
| Female | 272 (41%) |
| BMI (kg/m2) | 23.4 (5.2) |
| Diabetes | 191 (29%) |
| Insulin therapy | 63 (9%) |
| ASA score: | |
| Grade I | 59 (9%) |
| Grade II | 495 (74%) |
| Grade III | 115 (17%) |
| Cancer | 528 (79%) |
| Pre-operative chemotherapy | 34 (5%) |
| Jaundice | 470 (70%) |
| Haemoglobin serum levels (g/dl) | 12.8 (1.5) |
| Operative time (min) | 399 (82) |
| Operative blood loss (ml) | 573 (362) |
BMI, body mass index; ASA, American Society of Anesthesiologist.
Data are number of patients (%), or mean (standard deviation).